Mu Ping, Zhou Juhua, Ma Xinting, Zhang Guichun, Li Yanmin
Pharmazie. 2016 Aug 1;71(8):434-438. doi: 10.1691/ph.2016.5904.
Endometriosis (EMS), characterized by the presence and growth of functional en do met rial-like tissues outside the uterine cavity, is a common and benign gyneco logical disorder with a poorly understood and somewhat enigmatic etiopathogenesis and pathophysiology. MicroRNAs (miRNAs) are single-stranded 19-25 nucleotide-long RNAs and have an important role in post-transcriptional gene silencing by base pairing with target mRNAs. Recent research has shown that miRNAs and their target mRNAs are differentially expressed in endometriosis and other disorders of the female reproductive system. In this paper, we review the recent progress in understanding the roles of miRNAs in endometriosis, and specific miRNAs as biomarkers and therapeutic targets for endometriosis.
子宫内膜异位症(EMS)的特征是子宫腔外存在并生长功能性子宫内膜样组织,是一种常见的良性妇科疾病,其病因发病机制和病理生理学鲜为人知且有些神秘。微小RNA(miRNA)是单链的19 - 25个核苷酸长的RNA,通过与靶mRNA碱基配对在转录后基因沉默中起重要作用。最近的研究表明,miRNA及其靶mRNA在子宫内膜异位症和女性生殖系统的其他疾病中差异表达。在本文中,我们综述了在理解miRNA在子宫内膜异位症中的作用方面的最新进展,以及特定miRNA作为子宫内膜异位症的生物标志物和治疗靶点的研究进展。